Glaxo Hit With Wrongful Death Suit Over Avandia

Law360, New York (October 2, 2007, 12:00 AM EDT) -- Fresh from surviving regulatory scrutiny over its controversial diabetes medication, British pharmaceutical giant GlaxoSmithKline is now battling claims by a Texas widow that the drug killed her husband.

In a first amended complaint filed Monday in the U.S. District Court for the Eastern District of Texas, Peggie Stanford of Dallas claims the drug company was negligent in the marketing of the prescription drug rosiglitazone, which sells in the U.S. under the brand names Avandia, Avandamet and Avandaryl.

Stanford filed the wrongful death suit on behalf of...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.